Navigation Links
The next generation: nanomagnets could replace semiconductors
Date:9/2/2007

Just as compact discs all but wiped out vinyl records, semiconductors could be on their way out, too.

A University of Houston professor has developed a similar disruptive technology, using magnetic cellular networks, that could yield such benefits as increased computing power that rivals what is possible with semiconductor integrated circuits.

Integrated circuits, which are a microscopic array of electronic circuits and components that have been implanted on the surface of a single chip of semiconducting material, have become the principal components of almost all electronic devices. Compared to the vacuum tubes and transistors that preceded them, integrated circuits have provided a low-cost, highly reliable way for computers to respond to a wider range of input and produce a wider range of output.

Dmitri Litvinov, associate professor of electrical and computer engineering and of chemical and biomolecular engineering in the Cullen College of Engineering at UH, is working with specially arranged assemblies of nanomagnets, or magnetic cellular networks, to replace conventional circuitry and significantly improve computing operations. His research involves a system of interacting magnetic nanocells that could combine logic, random access memory and data storage in a single nanomagnetic computing system.

Working from logic gates, which are at the heart of a computers ability to add, subtract, multiply and divide, Litvinov wants to demonstrate that the magnetization of adjacent magnets is possible and can be used to perform specific logic and computing operations, reversing the repulsive and attractive poles of magnets.

The significance is potentially ultra-high density of magnetic computing components for significantly higher computing power beyond what is expected to be achievable with semiconductor integrated circuits, said Litvinov, who also is the director of the Center for Nanomagnetic Systems at UH. Ad
'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert

Page: 1 2 3

Related biology technology :

1. Talking Bout My Generation: The Evolution of Online Marketing Research
2. IRS ruling could speed healthcare technology adoption
3. Tech upstart VoVision could disrupt the voice-recognition market
4. Its not Y2K, but changes to Daylight Saving Time could cause tech problems
5. Software tax dispute could go the Supreme Court
6. CellCura could start an invasion of stem cell firms
7. Businesses could bridge digital divide in Milwaukee with used computers
8. Inventions could fall prey to Monday morning quarterbacking
9. Milwaukee could be wireless in 18 months
10. Venture-backed firms could become eligible for federal SBIR grants
11. Protein lab could prosper under new owner

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...mary efficacy endpoint has been met for patients w...ncer, , QUEBEC CITY, Nov. 24 /PRNewswire-Firs...X: AEZ) (the "Company"), a global biopharmaceutica...y, today announced positive efficacy data from a P...onjugate, AEZS-108 (formerly AN-152), in patients ...
(Date:11/24/2009)...IN, November 24 Shire pl...y biopharmaceutical company, today,announced that ...gency for,velaglucerase alfa, the company,s enzyme...ent of Type 1 Gaucher disease. This is the third m...as been submitted, with previous,submissions in th...
(Date:11/24/2009)... CITY, Calif., Nov. 24 G...ed that Randy Scott, Genomic Health,s Executive Ch...ray Health Care Conference in New York City on Tue... access the live and subsequently archived webcast... section of Genomic Health,s website at http://in...
(Date:11/24/2009)... Program Connects Customers with Partners Vali...h DNA Genotek Products , ...ek , a leading provider of products for biological... today announced its new global partner program. T... Genotek,s partner community and is designed to he...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
... Shows Clear Promise as a Stable Long-acting Antic...rders., ThromboGenics NV (Euronext Brussels:THR),...ye disease, announced that the results of the,firs... at the prestigious,American Society of Hematology.... TB-402 is being co-developed in collaboration wi...
... Inc.,(Amex: TTG ), a leading manufacturer of ste...allograft) and animal (xenograft) tissue, today an...fourth quarter ended September,30, 2007., Summar..., -- Total fiscal year 2007 revenues increased 4... fiscal year 2007; -- Sales of spine products in...
...ion and GE,Healthcare Financial Services have prov...cured loan to Astex Therapeutics Limited. This rep...to a biotechnology company in,Europe., Astex Ther...he largest,privately-held biotech companies in the...t of small molecule drugs in areas of unmet medica...
Other Biology Technology:ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 2ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 3ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting 4Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 2Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 3Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 4Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 5Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 6Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 7Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 8Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 9Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 10Oxford Finance Corporation and GE Healthcare Financial Services Reaffirm Commitment to Biotech Sector in Europe 2
(Date:11/24/2009)... thousands of years it has been prescribed by trad...ents from headaches and stomach pain to fever and ...castle University have been able to scientifically...enata otherwise known as Brazilian mint. , Test...team led by researcher Graciela Rocha was able to ...
(Date:11/24/2009)...nts that keep weakened and flabby arteries from co... months, those stents are no longer needed -- once...ssary. Previously, doctors had no choice but to le...el Aviv University,s Department of Biomedical Engi...latform that carries drugs where they,re needed, t...
(Date:11/24/2009)...ATON ROUGE Antarctica has long held secrets of th...til recently, there has been very little informati...th miles of ice for millions of years. Now, a team...LSU have been funded to the tune of $10 million d... to get to the bottom of things literally. These ...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Race Insurance May Affect Testing of Kids in ER 59679 1Race Insurance May Affect Testing of Kids in ER 59679 2Transplant May Treat Metabolic Disorders in Womb 59677 1Transplant May Treat Metabolic Disorders in Womb 59677 2Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 1Chicago Veterinary Emergency Services Goes 24 7 for Emergency Care 59672 2
...28, 2009 Congressman James McGovern, D-Massachuse... (NIH) awards for two researchers at Worcester Pol...ing Center at Gateway Park. , Glenn Gaudette, PhD... WPI, will receive $403,000 over two years to adva...to restore function to damaged hearts. Terri Cames...
...e devastating effects on endangered species, but n...tion of a population of bighorn sheep. , The effe...rn sheep can be mathematically predicted, as descr...000 Biology members Barry Brook and Lochran Traill...studied a population of bighorn sheep introduced t...
...research team say they,ve made a big improvement i...and other biological materials one that may be a ... , It consists of a piece of synthetic antibody a...ical base, immersed in liquid. , If the protein t...will bind to these antibodies, immediately creatin...
Other Biology News:NIH funds work at WPI on regenerating heart tissue and preventing urinary tract infections 2A quicker, cheaper SARS virus detector -- one easily customizable for other targets 2
Chicken Anti-Human Quinolinate phosphoribosyltransferase Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-J Chain Monoclonal Antibody, Unconjugated, Clone M19/9J from CHEMICON
Tissue Stat from Biomeda Corporation
Clarion Mounting Medium - 6X100 ml from Biomeda Corporation
Biology Products: